Find out now if you qualify. Time is limited to file a claim. You may be entitled to compensation. Fill out the form below to see if you qualify.
Free Claim Review
We are here to listen and help.
Submit below to speak with our team.
Ronnie Roman Sexual Abuse Claim Help
Your Health Issues Could be Linked to Contaminated Water
Information submitted will be transmitted to a law firm. This communication is intended to be an attorney-client communication for purposes of evaluating your claim and will be kept confidential by the law firm. The communication does not create an attorney-client relationship and no relationship is formed until a fee agreement is signed by you and the law firm. I also have read and agree to your Privacy Policy
File Your Claim Now
April 2022: The MDL Paraquat class action judge will have a status conference on April 1st to review where the litigation is headed and how best to take the bellwether lawsuits forward for trial in November 2022. 44 new paraquat lawsuits have been added to the MDL in the last two weeks. At this pace, April 2022 will be the busiest month for new files yet. Last week, the parties filed their class-action bellwether picks with the Paraquat MDL judge. Those choices, however, have not been made public.
May 2022: In the last month, over 50 new cases have been added to the Paraquat Lawsuit Multidistrict Litigation (MDL). A group of six patients was recently selected by the Paraquat MDL court for the initial Paraquat Parkinson's disease bellwether trials. As a result, the first trial in November 2022 is approaching soon. The strategy is to select 16 paraquat claims from among the almost 1000 Parkinson's disease litigation claims filed. Following some limited fact discovery in these instances, paraquat attorneys on both sides submitted a preference list to the MDL court, ranking the 16 cases in order of priority. Attorneys for plaintiffs seek the finest facts for their clients, while defense attorneys want the worst. The judge whittled the list down to six Paraquat claims based on these rankings.
CLAIM UPDATES
We are here to listen and help answer all your questions. Contact us today for a Free Claim Review by filling out the form above.
Fill out the form above to learn if you qualify. It’s fast, free, and confidential. Don’t wait – your health and justice matter.
Together, we can fight back against PFAS contamination and its devastating health effects.
Seek Justice Today
Maryland Juvenile Detention
Abuse Claim Help
Jeff Brandow
Sexual Abuse
Claim Help
File Your Claim Now
Have you or a loved one been diagnosed with kidney or testicular cancer? You may be entitled to compensation due to exposure to harmful PFAS chemicals. Fill out the form above to determine if you qualify for a PFAS lawsuit.
How to Qualify for a Depo-Provera Claim:
Use of Depo-Provera
Diagnosis of Brain Tumor
Document Evidence
Submit The Form Above
Depo-Provera is an injectable birth control containing the synthetic hormone medroxyprogesterone acetate, is linked to an increased risk of meningioma, a rare brain tumor. This risk was not adequately disclosed to consumers or medical professionals. Studies, including those published in the Journal of the American Medical Association (JAMA), have shown that long-term use of Depo-Provera significantly raises the risk of developing meningiomas.
Claims against Pfizer, Inc., the drug’s manufacturer, alleges that the company knew or should have known about the increased risk of meningiomas—brain tumors that can cause severe neurological symptoms—especially with prolonged use. The claims state that Pfizer failed to adequately warn doctors and patients, rushed the drug to market without sufficient long-term studies, and prioritized profits over safety.
Due to the rising number of claims against Pfizer regarding Depo-Provera and brain tumors have been consolidated into multidistrict litigation (MDL) in federal court. Affected individuals may seek compensation for medical expenses, long-term care, and other damages, with the potential for federal court consolidation of cases.
Cancer Claim Direct
Victim Compensation Support
Notable Settlements
Kidney and Testicular Cancer:
A recent meta-analysis of 15 studies, which included 10 cohort and 5 case-control studies, found that overall PFAS exposure was associated with an 18% higher risk of kidney cancer, with high-level exposure raising the risk by 74%. The National Academies in 2022 also concluded that there is sufficient evidence to support the association between PFAS exposure and kidney cancer. For testicular cancer, the same meta-analysis indicated that high PFAS exposure was linked to a 2.2-fold increased risk, although the result was on the borderline of statistical significance. Studies of U.S. Air Force servicemen have shown elevated testicular cancer risks associated with blood levels of PFAS from firefighting foam exposure, and laboratory research has demonstrated that certain PFAS compounds can accelerate testicular tumor growth in animals.
Additional research supports these findings. An ecological study in the United States suggested that PFAS in drinking water could contribute to approximately 6,800 cancer cases annually, including kidney and testicular cancers, although the study did not break down precise numbers by cancer type.
Associated Health Risks:
If you have been diagnosed with any of these conditions, it’s time to take action. Our experienced legal team is here to help you determine if you qualify for compensation. By joining a PFAS lawsuit, you can seek justice and hold manufacturers accountable for their negligence.
Understanding PFAS Exposure
Per- and polyfluoroalkyl substances (PFAS) are a group of man-made chemicals used in the manufacturing of countless everyday products due to their resistance to heat, water, and oil. Unfortunately, these chemicals do not break down in the environment or the human body, earning them the nickname "forever chemicals."
PFAS contamination is widespread, affecting drinking water supplies and accumulating in soil, wildlife, and humans. Nearly every American has detectable levels of PFAS in their bloodstream.
Numerous lawsuits have been filed against manufacturers and users of PFAS, leading to substantial settlements:
3M Settlement: In June 2023, 3M agreed to a $10.3 billion settlement to address PFAS contamination in public water systems.
DuPont, Chemours, and Corteva Settlement: These companies collectively agreed to a $1.18 billion settlement to resolve PFAS-related claims.
New Jersey Settlement: In 2025, New Jersey secured a historic $450 million settlement with 3M for PFAS contamination.
These settlements highlight the significant legal repercussions for companies linked to PFAS contamination and underscore the ongoing concerns regarding the health impacts of these chemicals.
QUALIFY IN MINUTES
